Search

Search Constraints

You searched for: Author/Creator Erbilgin, Yucel

Search Results

1. Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature. Issue 4 (21st April 2018)

2. Prognostic gene alterations and clonal changes in childhood B-ALL. (August 2019)

3. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia. (12th April 2021)

4. Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia. Issue 12 (15th October 2022)

5. High TUBB2A expression in childhood T‐ALL is correlated with the clinical outcome. (14th June 2020)

6. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Issue 1 (2nd January 2019)

7. Prognostic Significance of NOTCH1 and FBXW7 Mutations in Pediatric T-ALL. Issue 6 (30th May 2013)

8. Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia. (2nd May 2023)